Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
The current price of AVG.XETRA is €8.46 EUR — it has increased by +0% in the past 24 hours. Watch Avantor stock price performance more closely on the chart.
What is Avantor stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Avantor stocks are traded under the ticker AVG.XETRA.
When is the next Avantor earnings date?▼
Avantor is going to release the next earnings report on July 23, 2026.
What were Avantor earnings last quarter?▼
AVG.XETRA earnings for the last quarter are 0.15 EUR per share, whereas the estimation was 0.13 EUR resulting in a +8.3% surprise. The estimated earnings for the next quarter are N/A EUR per share.